A new trading day began on Tuesday, with Cg Oncology Inc (NASDAQ: CGON) stock price up 6.84% from the previous day of trading, before settling in for the closing price of $24.86. CGON’s price has ranged from $14.80 to $40.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 122.33% over the past five years. Meanwhile, its annual earnings per share averaged -32.58%. With a float of $44.88 million, this company’s outstanding shares have now reached $76.22 million.
Let’s look at the performance matrix of the company that is accounted for 113 employees. In terms of profitability, gross margin is 98.85%, operating margin of -22032.95%, and the pretax margin is -11656.56%.
Cg Oncology Inc (CGON) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cg Oncology Inc is 41.12%, while institutional ownership is 71.47%. The most recent insider transaction that took place on Apr 28 ’25, was worth 30,760. In this transaction Director of this company sold 1,000 shares at a rate of $30.76, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Director sold 1,000 for $28.00, making the entire transaction worth $28,000. This insider now owns 0 shares in total.
Cg Oncology Inc (CGON) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -32.58% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Here are Cg Oncology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 30.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3067.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.39, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.70 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Cg Oncology Inc (NASDAQ: CGON) saw its 5-day average volume 1.19 million, a positive change from its year-to-date volume of 1.08 million. As of the previous 9 days, the stock’s Stochastic %D was 74.77%. Additionally, its Average True Range was 2.16.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 67.20%, which indicates a significant increase from 60.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 128.23% in the past 14 days, which was higher than the 85.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.87, while its 200-day Moving Average is $30.67. Nevertheless, the first resistance level for the watch stands at $27.65 in the near term. At $28.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $30.22. If the price goes on to break the first support level at $25.07, it is likely to go to the next support level at $23.59. The third support level lies at $22.50 if the price breaches the second support level.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
With a market capitalization of 2.02 billion, the company has a total of 76,225K Shares Outstanding. Currently, annual sales are 1,140 K while annual income is -88,040 K. The company’s previous quarter sales were 50 K while its latest quarter income was -34,450 K.
